BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Joglekar K, Eason JD, Molnar MZ. Do we really need more evidence to use hepatitis C positive donor kidney more liberally? Clin Kidney J 2017;10:560-3. [PMID: 28835817 DOI: 10.1093/ckj/sfx067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Molnar MZ, Nair S, Cseprekal O, Yazawa M, Talwar M, Balaraman V, Podila PSB, Mas V, Maluf D, Helmick RA, Campos L, Nezakatgoo N, Eymard C, Horton P, Verma R, Jenkins AH, Handley CR, Snyder HS, Cummings C, Agbim UA, Maliakkal B, Satapathy SK, Eason JD. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience. Am J Transplant 2019;19:3046-57. [PMID: 31306549 DOI: 10.1111/ajt.15530] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 22.7] [Reference Citation Analysis]
2 Eisenberger U, Friebus-Kardash J, Guberina H, Kribben A, Witzke O, Willuweit K, Gerken G, Herzer K. Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function. Transplant Direct 2019;5:e419. [PMID: 30656217 DOI: 10.1097/TXD.0000000000000860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Shike H, Kadry Z, Imamura-Kawasawa Y, Greene W, Riley T, Nathan HM, Hasz RD, Jain A. Hepatitis C virus (HCV) RNA level in plasma and kidney tissue in HCV antibody-positive donors: Quantitative comparison. Clin Transplant 2018;32:e13358. [PMID: 30044009 DOI: 10.1111/ctr.13358] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]